The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced considerable risk . Investors are now grappling with the impact of lower-cost alte